Geneva, Oct. 15 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134079) titled 'Association of TROP-2-Expressing Circulating Tumor Cells with Efficacy of Disease-Free-Survival in Breast Cancer: A Prospective Cohort Study' on Oct. 10.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Shunde Hospital of Southern Medical University(The First People's Hospital of Shunde)
Condition:
Breast cancer
Intervention:
Trop-2 high expression ::Observational studies without intervention
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2022-07-10
Target Sample Size: Trop-2 high expression ::40;Trop-2 low expression:40;
Countries of Recruitmen...